🧬 Who wants to live forever? That bold question kicked off the #Continuity7 Debate this week at the Mumford Theatre, Cambridge. We dove into #longevity science, ethics & AI-powered biotech with a packed house & brilliant panel: 🔹 David Rubinsztein Cambridge University 🔹 Monty

Experts are exploring the emerging role of necrosis in ageing. "Necrosis has been hiding in plain sight ... it’s been largely overlooked" - Dr Carina Kern, CEO at LinkGevity biosciencetoday.co.uk/could-cell-dea… #bioresearch #lifesciences #clinicaltrials

What if we could block cell death itself to slow #aging? Excited to speak at Longevity Summit Dublin on LinkGevity’s #AntiNecrotic tech - the first to directly inhibit #necrosis, a key driver of tissue decline. See you in Dublin! Trinity College Dublin #longevity #ageing

Great to see our recent Nature Oncogene paper on targeting necrosis as a potential intervention for aging featured on the front page of Bioscience Today! 🧬📰 #AgingResearch #CellBiology #ScienceNews reveela.com/publication/78…

Understanding human #ageing Great write up in MedNous of our #Nature Oncogene paper #Necrosis as a fundamental driver of loss of #resilience and biological decline: what if we could intervene?" Dr Carina Kern mednous.com

Check out the latest episode on Base to Base biotech #podcast with Dr Carina Kern, Domain Therapeutics & SandboxAQ deeptechdigest.com/biotech/base-t… #ageing #longevity

CEO of LinkGevity Dr Carina Kern guests on this Base to Base Biotech podcast to share the science behind the Anti-Necrotic™-a first-in-class compound targeting necrosis, a hidden driver of ageing, tissue failure, and biological decline. 🎧 ow.ly/NHwo50WmRug

Great interview on our exciting #aging intervention by Dr Carina Kern Keith Siew! #longevity #innovation #biotech

Great article on our work by Popular Mechanics on our novel approach to aging 🔬 🧬

A Revolutionary New Drug Could Stop Your Cells From Self-Destructing—And Hit the Pause Button on Aging popularmechanics.com/science/health…

“Can a new drug help us to live longer?” 💊Check out this #podcast with Dr Carina Kern Serena Kern-Libera and Damian M. Bailey on the The Observer - they discuss #space, #ageing and LinkGevity's Anti-Necrotic drug #innovation! Jon Ungoed-Thomas Rebecca Moore

“Can a new drug help us to live longer?” 💊 Thanks for the great #podcast on our work The Observer. We discuss #space, #ageing and our Anti-Necrotic drug #innovation at LinkGevity with Damian M. Bailey and Serena Kern-Libera! 🚀 Thanks Jon Ungoed-Thomas Rebecca Moore Keith Siew

Biotech start-ups on quest for ‘holy grail’ anti-ageing drug From anti-necrotic drugs to gene therapy, big tech has longevity in its sights. observer.co.uk/news/business/…

How #necrosis could be the answer to slowing tissue degeneration and #aging. Dr Carina Kern, Serena Kern-Libera, Justin Stebbing and Damian M. Bailey spoke with Jon Ungoed-Thomas at the The Observer recently on LinkGevity's Anti-Necrotic technology 🔗observer.co.uk/news/business/…

Biotech start-ups on quest for ‘holy grail’ anti-ageing drug From anti-necrotic drugs to gene therapy, big tech has longevity in its sights Jon Ungoed-Thomas observer.co.uk/news/business/… | The Observer

Biotech start-ups on quest for ‘holy grail’ anti-ageing drug From anti-necrotic drugs to gene therapy, big tech has longevity in its sights. bit.ly/3IHCzuB

NASA astronaut and microbiologist Kate Rubins retired Monday after 16 years with the agency. During her time with NASA, Rubins completed two long-duration missions aboard the International International Space Station , logging 300 days in space and conducting four spacewalks.

⭐ Shining the spotlight on people and companies that are a force and pushing the longevity ecosystem in the UK forward ⭐ 🧵Meet Dr. Dr Carina Kern, the Founder and CEO of LinkGevity. She has co-founded LinkGevity in 2023 along with her sister Serena Kern-Libera.

"Few realise that the kidneys are the secret longevity arbitrators" Interesting article in the press today about the link between #kidneys and #longevity- with of course ties in with our strategy at LinkGevity! londondaily.news londondaily.news/why-kidney-hea…